In a first-of-its-kind study collaboration, new research has uncovered that chronic lymphocytic leukemia (CLL) cells may switch between different survival signals, helping explain why treatments work well for some patients but stop working for others. These findings could ultimately help pave the way for more personalized treatment.
Related Posts
Free-Range Parenting Is Back in the News, but Not in a Good Way
“Mother charged after 5-year-old walks to pond alone, stirring parenting debate.” —The Washington Post, September 6, 2026. “Mom found guilty of abuse for letting 5-year-old […]
Persistent pain might become linked with how individuals regard themselves, mind scans suggest
For people with persistent neck and back pain, day-to-day movements like flexing down to link their footwear or picking up a grocery store bag can […]
The European Commission and WHO extend their strategic cooperation to deliver better health for all
At the EU-WHO Strategic Dialogue on Health between the European Commissioner for Health and Food Safety Stella Kyriakides and Dr Tedros Adhanom Ghebreyesus, WHO Director-General, […]